Vaccinopolis
Vaccinopolis, a cutting-edge clinical testing hub established by the University of Antwerp, delivers comprehensive vaccine research and development services.
Company facts
- Employees
- 50
- Headquarters
- Belgium
- Type
- Academic
About
Vaccinopolis, a cutting-edge clinical testing hub established by the University of Antwerp, delivers comprehensive vaccine research and development services. The facility boasts a 30-bed quarantine unit and state-of-the-art BSL-2 and BSL-3 laboratories, enabling rigorous safety-critical studies. A dedicated ambulatory trial unit supports large-scale, real-world efficacy assessments, bridging laboratory findings to clinical outcomes. Vaccinopolis' integrated, university-backed infrastructure positions it as a premier partner for biotech and pharmaceutical companies seeking accelerated, compliant vaccine development.